Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea

The effect of hydroxcarbamide therapy on survival of children with sickle cell disease

(2013) Clarisse Lopes de Castro Lobo et al.   BRITISH JOURNAL OF HAEMATOLOGY

Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program

(2013) Kerri A. Nottage et al.   PLoS One

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia

(2011) R. E. Ware et al.   BLOOD

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

(2011) Winfred C Wang et al.   LANCET

Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY-HUG phase III clinical trial

(2011) Patrick T. McGann et al.   PEDIATRIC BLOOD & CANCER

Glomerular hyperfiltration and albuminuria in children with sickle cell anemia

(2011) Banu Aygun et al.   PEDIATRIC NEPHROLOGY

Hydroxyurea for Children with Sickle Cell Disease

(2010) Matthew M. Heeney et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)

(2009) E. Voskaridou et al.   BLOOD

Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea

(2008) Sharon A. Singh et al.   PEDIATRIC BLOOD & CANCER

Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease in the First Decade of Life

(2008) T. V. Adamkiewicz et al.   PEDIATRICS